UNSPSC 51391501: Imoxiterol

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UR4924C6G2. European Medicines Agency schedules Imoxiterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08157MIG. Imoxiterol generally arises in the molecular formula C20H25N3O3.

UNSPSC 51391501 Imoxiterol, a Commodity code, covers pharmaceutical products and related systems procured by state and local health agencies. Recent solicitations under this code reflect state and county procurement of opioid-reversal medications and drug deactivation systems to support public health and community safety initiatives. Seminole County, Florida issued an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the county's Community Health Building; the procurement required electronic bid submission through the county's e-Procurement Portal, E-Verify compliance, drug-free workplace certification, and fixed-fee pricing on a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission posted a Request for Information in April 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs for self-insured employee group health plans and state agencies, seeking vendor experience with direct contracting models outside traditional pharmacy benefit manager and group purchasing organization channels. Issuing bodies include county health departments and state health and human services agencies pursuing pharmaceutical procurement to address opioid response, substance abuse mitigation, and prescription fulfillment efficiency.

Geographic activity centers on Florida and Texas based on recent postings. The Seminole County IFB (IFB60459723LAS, due July 26, 2023) and the Texas HHS Commission RFI (HHS0017013, posted April 3, 2026) represent the primary recent solicitations under this code. Vendors responding to Seminole County's naloxone and drug deactivation system procurement must absorb all shipping and delivery costs and maintain workers' compensation, commercial general liability, and professional liability insurance; the contract may be subject to FEMA compliance requirements including Clean Air Act and Federal Water Pollution Control Act adherence. The Texas RFI does not establish formal evaluation criteria, site visits, or binding timelines; it functions as exploratory market intelligence to inform future RFP development rather than as a competitive procurement vehicle with award amounts or budget ranges.